N-((1S,4S)-4-(2-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-5-methyl-7-oxopyrido[2,3-d]pyrimidin-8(7H)-yl)cyclohexyl)-1-naphthamide

ID: ALA4859914

PubChem CID: 164618021

Max Phase: Preclinical

Molecular Formula: C37H41N7O3

Molecular Weight: 631.78

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(C)cc(=O)n([C@H]3CC[C@@H](NC(=O)c4cccc5ccccc45)CC3)c2n1

Standard InChI:  InChI=1S/C37H41N7O3/c1-24-21-34(45)44(27-13-11-26(12-14-27)39-36(46)30-10-6-8-25-7-4-5-9-29(25)30)35-31(24)23-38-37(41-35)40-32-16-15-28(22-33(32)47-3)43-19-17-42(2)18-20-43/h4-10,15-16,21-23,26-27H,11-14,17-20H2,1-3H3,(H,39,46)(H,38,40,41)/t26-,27+

Standard InChI Key:  NBVXUPNQWNJNAB-MKPDMIMOSA-N

Molfile:  

 
     RDKit          2D

 47 53  0  0  0  0  0  0  0  0999 V2000
   22.9147  -16.4884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9214  -15.6634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6365  -15.2568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3490  -15.6709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3464  -16.4959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0589  -16.9141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0521  -17.7391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3372  -18.1458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6247  -17.7317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6272  -16.9067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1997  -16.8993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1930  -17.7242    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.4873  -16.4809    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.4939  -15.6559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7815  -15.2377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7840  -14.4127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4991  -14.0061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2115  -14.4243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2090  -15.2493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3657  -12.7553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0782  -13.1736    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.7933  -12.7628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7958  -11.9378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0833  -11.5237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3683  -11.9303    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.5150  -11.5312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2274  -11.9494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2208  -12.7744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5057  -13.1811    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.9332  -13.1885    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.5175  -10.7062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6465  -13.1661    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.9341  -12.7520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2190  -13.1587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5066  -12.7445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5091  -11.9196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2283  -11.5088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9407  -11.9271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7966  -11.5013    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.0816  -11.9122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3691  -11.4938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3716  -10.6689    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.0908  -10.2622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8033  -10.6764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6592  -10.2506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2124  -13.9836    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.4973  -14.3945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  1 10  2  0
  5 10  1  0
  1 11  1  0
 11 12  2  0
 11 13  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 14 19  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 20 25  2  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 22 29  1  0
 23 26  1  0
 28 30  2  0
 26 31  1  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 33 38  2  0
 39 40  1  0
 40 41  1  0
 41 42  1  0
 42 43  1  0
 43 44  1  0
 39 44  1  0
 42 45  1  0
 36 39  1  0
 46 47  1  0
 34 46  1  0
 32 33  1  0
 20 32  1  0
 17 29  1  1
 14 13  1  1
M  END

Alternative Forms

1. Parent:

   

   ALA4859914

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 631.78

Molecular Weight (Monoisotopic): 631.3271

AlogP: 5.67

#Rotatable Bonds: 7

Polar Surface Area: 104.62

Molecular Species: NEUTRAL

HBA: 9

HBD: 2

#RO5 Violations: 2

HBA (Lipinski): 10

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 2

CX Acidic pKa: ┄

CX Basic pKa: 7.84

CX LogP: 5.32

CX LogD: 4.74

Aromatic Rings: 5

Heavy Atoms: 47

QED Weighted: 0.24

Np Likeness Score: -1.27

References

1. Huang M, Huang Y, Guo J, Yu L, Chang Y, Wang X, Luo J, Huang Y, Tu Z, Lu X, Xu Y, Zhang Z, Zhang Z, Ding K..  (2021)  Pyrido[2, 3-d]pyrimidin-7(8H)-ones as new selective orally bioavailable Threonine Tyrosine Kinase (TTK) inhibitors.,  211  [PMID:33248853] [10.1016/j.ejmech.2020.113023]

Source

Source(1):

• Scientific Literature